
Sign up to save your podcasts
Or
Our co-hosts discuss the currently active & accruing NRG-GI008 study, also known as the "CIRCULATE-NORTH AMERICA" study. This study will evaluate what kind of chemotherapy to recommend to patients based on the presence or absences of circulating tumor DNA (ctDNA) after surgery for colon cancer.
5
77 ratings
Our co-hosts discuss the currently active & accruing NRG-GI008 study, also known as the "CIRCULATE-NORTH AMERICA" study. This study will evaluate what kind of chemotherapy to recommend to patients based on the presence or absences of circulating tumor DNA (ctDNA) after surgery for colon cancer.
90,949 Listeners
30,845 Listeners
32,291 Listeners
59,322 Listeners
2,433 Listeners
3,336 Listeners
111,917 Listeners
56,231 Listeners
7,953 Listeners
360 Listeners
62 Listeners
15,335 Listeners
31 Listeners
132 Listeners
492 Listeners